Argus Pharmaceuticals   Report issue

For profit Phase 1
Founded: Chongqing China (2007)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

didanosine (videx) (1 trial)

nystatin (mycostatin) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 1)

Communicable Diseases (Phase 1)

HIV Infections (Phase 1)

Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 2